INCY vs NVS
Incyte vs Novartis AG — AI-powered side-by-side comparison
| Metric | INCY | NVS |
|---|---|---|
| AI Score | 71 | 71 |
| Price | $119.81 | $154.44 |
| P/E Ratio | 14.74× | 23.58× |
| ROE | 24.9% | 30.5% |
| Revenue Growth YoY | — | — |
| Gross Margin | 92.6% | 74.3% |
| Debt / Equity | 0.01× | 1.18× |
| Dividend Yield | 0.0% | 2.9% |
| RSI (14) | 50.5 | 46.9 |
| Beta | 0.758 | 0.46 |
| Expected Upside | — | +1.2% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
INCY Full Analysis
NVS Full Analysis